Literature DB >> 11978522

The circumferential margin in rectal cancer. Recommendations based on the Dutch Total Mesorectal Excision Study.

T Wiggers1, C J H van de Velde.   

Abstract

A very low local recurrence rate in rectal cancer is possible with optimal staging, preoperative radiotherapy and the use of total mesorectal excision (TME). Data from a study where patients were randomised for preoperative radiotherapy (or not) and complete removal of the tumour and mesorectum were examined. A consensus meeting was held to discuss the data in which the following guidelines for implementation were made. Adequate imaging is necessary to increase the likelihood of a R0 resection. Advances cases (possible margin to the endopelvicfascie less than 2 mm) need a long course of preoperative radiotherapy. Primary resectable cases benefit from a short course of radiation directly followed by surgery. A continuous quality control of surgery is mandatory in order to maintain the skill for a TME. A complete pathology report is important for the quality control of the surgical treatment and to predict the outcome of treatment. All of the involved disciplines in the diagnosis and treatment of rectal cancer should focus on the circumferential margin to guide for optimal treatment. Multidisciplinary teams are important for the achievement of optimal treatment planning of rectal cancer patients and maintenance of the highest level of quality control.

Entities:  

Mesh:

Year:  2002        PMID: 11978522     DOI: 10.1016/s0959-8049(02)00054-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

Review 1.  The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment.

Authors:  Jeremy R Parfitt; David K Driman
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

2.  Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia.

Authors:  Michael R Torkzad; Karl A Hansson; Johan Lindholm; Anna Martling; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2006-12-21       Impact factor: 5.315

3.  The mesorectum: morphometric assessment with magnetic resonance imaging.

Authors:  Michael R Torkzad; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

4.  Transanal natural orifice specimen extraction for laparoscopic anterior resection in rectal cancer.

Authors:  Fang-Hai Han; Li-Xin Hua; Zhi Zhao; Jian-Hai Wu; Wen-Hua Zhan
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

5.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

Review 6.  Pouch reconstruction in the pelvis.

Authors:  H-P Bruch; O Schwandner; S Farke; J Nolde
Journal:  Langenbecks Arch Surg       Date:  2003-03-25       Impact factor: 3.445

Review 7.  [Surgical therapy of rectal carcinoma].

Authors:  H-P Bruch; O Schwandner; R Keller; S Farke; T H K Schiedeck
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

8.  Laparoscopic surgery for rectal cancer: outcomes in 513 patients.

Authors:  Oktar Asoglu; Emre Balik; Enver Kunduz; Sumer Yamaner; Ali Akyuz; Mine Gulluoglu; Yersu Kapran; Dursun Bugra
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

9.  Occurrence and prognostic value of circumferential resection margin involvement for patients with rectal cancer.

Authors:  Cun Wang; Zong-guang Zhou; Yong-yang Yu; Ye Shu; Yuan Li; Lie Yang; Li Li
Journal:  Int J Colorectal Dis       Date:  2009-01-20       Impact factor: 2.571

10.  Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial.

Authors:  Mostafa Abd Elwanis; Doaa W Maximous; Mohamed Ibrahim Elsayed; Nabiel N H Mikhail
Journal:  World J Surg Oncol       Date:  2009-06-09       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.